The applied statistical approach highly influences the 99th percentile of cardiac troponin I

Clinical Biochemistry

Volumn 49, Issue 15, 2016, Pages 1109-1112

  Eggers, Kai M ^a   Apple, Fred S ^b,c   Lind, Lars ^a   Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

99th percentile; Cardiac troponin; Statistics; Upper reference level

Indexed keywords

TROPONIN I;

AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; COMMUNITY LIVING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HARRELL DAVIS BOOTSTRAP METHOD; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; MALE; NONPARAMETRIC TEST; NORMAL HUMAN; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ROBUST METHOD; STATISTICAL ANALYSIS; REFERENCE VALUE; STANDARDS;

FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; REFERENCE VALUES; TROPONIN I;

EID: 84991720196     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.08.012     Document Type: Article

References (17)

1. [1] Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035, 10.1161/CIR.0b013e31826e1058.
2. [2] Sandoval, Y., Apple, F.S., The global need to define normality: the 99th percentile value of cardiac troponin. Clin. Chem. 60 (2014), 455–462, 10.1373/clinchem.2013.211706.
3. [3] Apple, F.S., Jaffe, A.S., Collinson, P., Mockel, M., Ordonez-Llanos, J., Lindahl, B., et al. IFCC educational materials on selected analytical and clinical applications of high-sensitivity cardiac troponin assays. Clin. Biochem. 48 (2015), 201–203, 10.1016/j.clinbiochem.2014.08.021.
4. [4] Clinical Laboratory Standards Institute, Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline - Third Edition. CLSI Document EP28-A3c. 2008, CLSI, Wayne (PA).
5. [5] Krintus, M., Kozinski, M., Boudry, P., Lackner, K., Lefèvre, G., Lennartz, L., et al. Defining normality in a European multinational cohort: critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I. Int. J. Cardiol. 187 (2015), 256–263, 10.1016/j.ijcard.2015.03.282.
6. [6] Harrell, F.E., Davis, C.E., A new distribution-free quantile estimator. Biometrika 69 (1982), 635–640.
7. [7] Dixon, W.J., Processing data for outliers. Biometrics 9 (1983), 74–89.
8. [8] Reed, A.H., Henry, R.J., Mason, W.B., Influence of statistical method used on the resulting estimate of normal range. Clin. Chem. 17 (1971), 275–284.
9. [9] Tukey, J.W., Exploratory Data Analysis. 1977, Addison-Wesley, Reading (PA).
10. [10] Kimenai, D.M., Henry, R.M., van der Kallen, C.J., Dagnelie, P.C., Schram, M.T., Stehouwer, C.D., et al. Direct comparison of clinical decision limits for cardiac troponin T and I. Heart 102 (2016), 610–616, 10.1136/heartjnl-2015-308917.
11. [11] Lind, L., Fors, N., Hall, J., Marttala, K., Stenborg, A., A comparison of three different methods to evaluate endothelium-dependent vasodilatation in the elderly. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 2368–2375.
12. [12] Eggers, K.M., Lind, L., Venge, P., Lindahl, B., Factors influencing the 99th percentile of cardiac troponin I evaluated in community-dwelling individuals at 70 and 75 years of age. Clin. Chem. 59 (2013), 1068–1073, 10.1373/clinchem.2012.196634.
13. [13] Abhayaratna, W.P., Marwick, T.H., Becker, N.G., Jeffery, I.M., McGill, D.A., Smith, W.T., Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide. Am. Heart J. 152 (2006), 941–948.
14. [14] Costello-Boerrigter, L.C., Boerrigter, G., Redfield, M.M., Rodeheffer, R.J., Urban, L.H., Mahoney, D.W., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. Determinants and detection of left ventricular dysfunction. J. Am. Coll. Cardiol. 47 (2006), 345–353.
15. [15] Krintus, M., Kozinski, M., Boudry, P., Capell, N.E., Köller, U., Lackner, K., et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin. Chem. Lab. Med. 52 (2014), 1657–1665, 10.1515/cclm-2014-0107.
16. [16] Koerbin, G., Abhayaratna, W.P., Potter, J.M., Apple, F.S., Jaffe, A.S., Ravalico, T.H., Hickman, P.E., Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin. Biochem. 46 (2013), 1636–1643, 10.1016/j.clinbiochem.2013.08.004.
17. [17] Hammarsten, O., Fu, M.L., Sigurjonsdottir, R., Petzold, M., Said, L., Landin-Wilhelmsen, K., et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin. Chem. 58 (2012), 628–637, 10.1373/clinchem.2011.171496.